概要

DIA’s Canadian Pharmacovigilance and Risk Management Strategies Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.

Great learning opportunity with Health Canada speakers to get the latest updates and be able to directly ask them questions.
-Previous Attendee

Very informative. I liked how we had the opportunity to discuss issues/topics with Health Canada.
-Previous Attendee

Highlights

Risk management for opioids
Cybersecurity and implications for pharmacovigilance
Round table with Inspector
Canada vigilance update by Health Canada

Travel Once, Learn Twice!
This year the Canadian Pharmacovigilance and Risk Management Strategies Conference will be co-located with the DIA Annual Canadian Meeting. Maximize your education and time by attending both! Save* $150 when you register for both!
*You must register for both events at the same time.

Featured

Want to learn more about Canadian Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Continuing Education

参加対象

Professionals involved in:

Regulatory

Policy

Clinical trial disclosure policies and compliance

Clinical operations or clinical research

Medical writing and communications

Legal

Market access

学習目的

At the conclusion of this conference, participants should be able to:

Describe the current Canadian regulatory framework for pharmacovigilance
Identify current pharmacovigilance issues facing Marketing Authorization Holders in Canada
Describe the challenges of cybersecurity and strategies to cybersecurity implementation

プログラム委員会

Rita Cassola, RPh Executive Director PV
Certus PV Services Inc, Canada
Marcia Bailey, BSN, MHS, RN Safety Evaluation and Risk Management Scientific Director
GSK, Canada
Colin D'Cunha, MD, MHS, FRCPC Director, Global Medical Affairs
Apotex Inc., Canada
Melissa Hunt, MSc Director
Health Canada, Canada
Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada